Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
HKSE - Delayed Quote HKD

Beijing Biostar Pharms Co Ltd (2563.HK)

Compare
4.410
-0.930
(-17.42%)
As of March 31 at 4:08:28 PM GMT+8. Market Open.
Advanced Chart
Loading Chart for 2563.HK
  • Previous Close 5.340
  • Open 5.360
  • Bid 4.410 x --
  • Ask 4.450 x --
  • Day's Range 4.280 - 5.360
  • 52 Week Range 4.280 - 39.500
  • Volume 371,200
  • Avg. Volume 105,793
  • Market Cap (intraday) 1.608B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 7, 2025 - Apr 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 35.66

Recent News: 2563.HK

View More
View More

Performance Overview: 2563.HK

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2563.HK
76.79%
HANG SENG INDEX (^HSI)
2.62%

1-Year Return

2563.HK
79.49%
HANG SENG INDEX (^HSI)
23.09%

3-Year Return

2563.HK
79.49%
HANG SENG INDEX (^HSI)
5.61%

5-Year Return

2563.HK
79.49%
HANG SENG INDEX (^HSI)
15.12%

Compare To: 2563.HK

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

2563.HK
Beijing Biostar Pharms Co Ltd
4.410
-17.42%
Mkt Cap HKD 1.608B
Industry Biotechnology
1801.HK
INNOVENT BIO
41.600
-17.21%
Mkt Cap HKD 67.742B
Industry Biotechnology
ZLAB
Zai Lab Limited
31.77
-13.41%
Mkt Cap 4.061B
Industry Biotechnology

Statistics: 2563.HK

View More

Valuation Measures

Annual
As of 4/3/2025

  • Market Cap

    1.61B

  • Enterprise Value

    1.07B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    22.04

  • Price/Book (mrq)

    2.24

  • Enterprise Value/Revenue

    14.66

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: 2563.HK

View More
View More

Company Insights: 2563.HK

Research Reports: 2563.HK

View More
View More

People Also Watch

2567.HK Qiniu Limited
0.860
-9.47%
 
2566.HK Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
5.890
-9.66%
 
2531.HK GL-Carlink Technology Holding Limited
19.960
-9.07%
 
2576.HK Zhejiang Taimei Medical Technology Co., Ltd.
3.250
-15.58%
 
2559.HK Dida Inc.
1.060
-7.83%
 
2551.HK APT Electronics Co Ltd
3.060
-11.30%
 
2549.HK Carote Ltd
4.060
-20.08%
 
2587.HK HealthyWay Inc
29.600
-3.90%
 
2556.HK Marketingforce Management Ltd
38.900
-22.74%
 
2562.HK Synagistics Limited
15.360
-13.22%
 
2560.HK Anhui Conch Material Tech Co
1.630
-8.94%
 
2582.HK Jiangsu Guofu Hydrogen Energy Equipment Co., Ltd.
105.200
-9.54%
 
2585.HK Mokingran Jewellery Group Co., Ltd.
15.140
-2.94%
 
2550.HK Easou Technology Holdings Limited
3.320
-14.87%
 
2569.HK Soft International Group Ltd
0.470
-6.00%
 
2577.HK InnoScience (Suzhou) Technology Holding Co., Ltd.
34.700
-16.79%